enow.com Web Search

  1. Ads

    related to: capecitabine survival rate for prostate cancer diagnosis

Search results

  1. Results from the WOW.Com Content Network
  2. Cancer survival rates - Wikipedia

    en.wikipedia.org/wiki/Cancer_survival_rates

    In the United States there has been an increase in the 5-year relative survival rate between people diagnosed with cancer in 1975-1977 (48.9%) and people diagnosed with cancer in 2007-2013 (69.2%); these figures coincide with a 20% decrease in cancer mortality from 1950 to 2014. [8]

  3. STAMPEDE (clinical trial) - Wikipedia

    en.wikipedia.org/wiki/STAMPEDE_(clinical_trial)

    James, Sydes & Clarke 2016 reported that "the addition of docetaxel to standard of care was associated with improved survival, with an HR of 0·78 and a difference in median survival of 10 months, as well as improvements in prostate-cancer-specific survival, failure-free survival, and skeletal-related events".

  4. Prostate cancer - Wikipedia

    en.wikipedia.org/wiki/Prostate_cancer

    Prostate cancer is the most diagnosed cancer in men in over half of the world's countries, and the leading cause of cancer death in men in around a quarter of countries. [ 91 ] Prostate cancer is rare in those under 40 years old, [ 92 ] and most cases occur in those over 60 years, [ 2 ] with the average person diagnosed at 67. [ 93 ]

  5. Capecitabine - Wikipedia

    en.wikipedia.org/wiki/Capecitabine

    Capecitabine, sold under the brand name Xeloda among others, is a anticancer medication used to treat breast cancer, gastric cancer and colorectal cancer. [3] For breast cancer it is often used together with docetaxel. [4] It is taken by mouth. [4] Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. [4]

  6. Five-year survival rate - Wikipedia

    en.wikipedia.org/wiki/Five-year_survival_rate

    Five-year survival rates can be used to compare the effectiveness of treatments. Use of five-year survival statistics is more useful in aggressive diseases that have a shorter life expectancy following diagnosis, such as lung cancer, and less useful in cases with a long life expectancy, such as prostate cancer.

  7. 1. More Americans are getting diagnosed with cancer - AOL

    www.aol.com/lifestyle/cancer-death-rates-falling...

    More younger people are being diagnosed with and dying from certain cancers, including colorectal cancer. From 2017 to 2021, the rate of these cancers rose by more than 3% per year among people ...

  1. Ads

    related to: capecitabine survival rate for prostate cancer diagnosis